EDGAR Filing Documents for 0001564590-17-018031

Form 8-K - Current report:

SEC Accession No. 0001564590-17-018031

Filing Date

2017-08-24

Accepted

2017-08-24 16:05:43

Documents

Period of Report

2017-08-22

Items

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	rare-8k_20170822.htm	8-K	20582
2	EX-99.1	rare-ex991_6.htm	EX-99.1	11676
3	EX-99.2	rare-ex992_7.htm	EX-99.2	15677
4	GRAPHIC	g2017082318174490114802.jpg	GRAPHIC	348834
5	GRAPHIC	g2017082318173835711417.jpg	GRAPHIC	9609
	Complete submission text file	0001564590-17-018031.txt		542749

Mailing Address 60 LEVERONI COURT NOVATO CA 94949

Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800

Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)